Literature DB >> 23584794

Radiation-induced TNFα cross signaling-dependent nuclear import of NFκB favors metastasis in neuroblastoma.

Sheeja Aravindan1, Mohan Natarajan, Terence S Herman, Natarajan Aravindan.   

Abstract

Ascertaining function-specific orchestration of NFκB in response to radiation may reveal a molecular blue-print that dictates induced relapse and metastasis of the neuroblastoma. We recently demonstrated that sustained activation of NFκB caused by ionizing radiation (IR)-initiated TNFα-NFκB feedback signaling leads to radioresistance and recurrence of neuroblastoma. We investigated whether muting IR-triggered or TNFα-dependent second-signaling feedback-dependent NFκB nuclear import results in limiting IR-altered invasion and metastasis. Neuroblastoma cells were exposed to 2 Gy and incubated for 1 h or 24 h. The cells were then treated with an NFκB-targeting peptide blocker, SN50. Upon confirming the blockade in DNA-binding activity, transcription driven transactivation of NFκB and secretion of soluble TNFα, transcriptional alterations of 93 tumor invasion/metastasis genes were assessed by using QPCR profiling and then were selectively validated at the protein level. Exposure to 2 Gy induced 63, 42 and 71 genes in surviving SH-SY5Y, IMR-32 and SK-N-MC cells, respectively. Blocking post-translational nuclear import of NFκB comprehensively inhibited both initial activation of genes (62/63, 34/42 and 65/71) triggered by IR and also TNFα-mediated second signaling-dependent sustained (59/63, 32/42 and 71/71) activation of tumor invasion and metastasis signaling molecules. Furthermore, alterations in the proteins MMP9, MMP2, PYK-2, SPA-1, Dnmt3b, Ask-1, CTGF, MMP10, MTA-2, NF-2, E-Cadherin, TIMP-2 and ADAMTS1 and the results of our scratch-wound assay validate the role of post-translational NFκB in IR-regulated invasion/metastasis. These data demonstrate that IR-induced second-phase (post-translational) NFκB activation mediates TNFα-dependent second signaling and further implies that IR induced NFκB in cells that survive after treatment regulates tumor invasion/metastasis signaling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23584794      PMCID: PMC7224632          DOI: 10.1007/s10585-013-9580-y

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  32 in total

1.  NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4.

Authors:  Gregory Helbig; Kent W Christopherson; Poornima Bhat-Nakshatri; Suresh Kumar; Hiromitsu Kishimoto; Kathy D Miller; Hal E Broxmeyer; Harikrishna Nakshatri
Journal:  J Biol Chem       Date:  2003-04-09       Impact factor: 5.157

Review 2.  NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.

Authors:  M J Lenardo; D Baltimore
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

3.  Low-dose γ-radiation-induced oxidative stress response in mouse brain and gut: regulation by NFκB-MnSOD cross-signaling.

Authors:  Jamunarani Veeraraghavan; Mohan Natarajan; Terence S Herman; Natarajan Aravindan
Journal:  Mutat Res       Date:  2010-11-04       Impact factor: 2.433

4.  Guggulsterone (GS) inhibits smokeless tobacco and nicotine-induced NF-κB and STAT3 pathways in head and neck cancer cells.

Authors:  Muzafar A Macha; Ajay Matta; S S Chauhan; K W Michael Siu; Ranju Ralhan
Journal:  Carcinogenesis       Date:  2010-12-22       Impact factor: 4.944

Review 5.  Role of nitric oxide in tumour progression: lessons from human tumours.

Authors:  L L Thomsen; D W Miles
Journal:  Cancer Metastasis Rev       Date:  1998-03       Impact factor: 9.264

6.  Patterning N-type and S-type neuroblastoma cells with Pluronic F108 and ECM proteins.

Authors:  Joseph M Corey; Caitlyn C Gertz; Thomas J Sutton; Qiaoran Chen; Katherine B Mycek; Bor-Shuen Wang; Abbey A Martin; Sara L Johnson; Eva L Feldman
Journal:  J Biomed Mater Res A       Date:  2010-05       Impact factor: 4.396

7.  Induction of nuclear factor kappa B after low-dose ionizing radiation involves a reactive oxygen intermediate signaling pathway.

Authors:  N Mohan; M L Meltz
Journal:  Radiat Res       Date:  1994-10       Impact factor: 2.841

8.  NFkappaB signaling related molecular alterations in human neuroblastoma cells after fractionated irradiation.

Authors:  Rakhesh Madhusoodhanan; Mohan Natarajan; Jamunarani Veeraraghavan; Terence S Herman; Ambarish Jamgade; Nisha Singh; Natarajan Aravindan
Journal:  J Radiat Res       Date:  2009-05-12       Impact factor: 2.724

9.  In vitro blockade of receptor activator of nuclear factor-kappaB ligand prevents osteoclastogenesis induced by neuroblastoma cells.

Authors:  Donatella Granchi; Ilaria Amato; Luca Battistelli; Sofia Avnet; Sergio Capaccioli; Laura Papucci; Martino Donnini; Andrea Pellacani; Maria Luisa Brandi; Armando Giunti; Nicola Baldini
Journal:  Int J Cancer       Date:  2004-10-10       Impact factor: 7.396

Review 10.  The experimental and clinical rationale for the use of S-phase-specific radiosensitizers to overcome tumor cell repopulation.

Authors:  C J McGinn; T J Kinsella
Journal:  Semin Oncol       Date:  1992-08       Impact factor: 4.929

View more
  4 in total

1.  Arctigenin Confers Neuroprotection Against Mechanical Trauma Injury in Human Neuroblastoma SH-SY5Y Cells by Regulating miRNA-16 and miRNA-199a Expression to Alleviate Inflammation.

Authors:  Jie Song; Na Li; Yang Xia; Zhong Gao; Sa-Feng Zou; Yu-Hui Yan; Shao-Heng Li; Yue Wang; Ya-Kun Meng; Jing-Xian Yang; Ting-Guo Kang
Journal:  J Mol Neurosci       Date:  2016-07-07       Impact factor: 3.444

2.  Targeting acquired oncogenic burden in resilient pancreatic cancer: a novel benefit from marine polyphenols.

Authors:  Sheeja Aravindan; Dinesh Babu Somasundaram; Somasundaram T Somasundaram; Mohan Natarajan; Terence S Herman; Natarajan Aravindan
Journal:  Mol Cell Biochem       Date:  2019-07-31       Impact factor: 3.396

3.  RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes.

Authors:  Faizan H Khan; Vijayabaskar Pandian; Satish Kumar Ramraj; Sheeja Aravindan; Mohan Natarajan; Seifollah Azadi; Terence S Herman; Natarajan Aravindan
Journal:  Oncotarget       Date:  2015-11-03

4.  Hormophysa triquerta polyphenol, an elixir that deters CXCR4- and COX2-dependent dissemination destiny of treatment-resistant pancreatic cancer cells.

Authors:  Sheeja Aravindan; Satishkumar Ramraj; Kathiresan Kandasamy; Somasundaram S Thirugnanasambandan; Dinesh Babu Somasundaram; Terence S Herman; Natarajan Aravindan
Journal:  Oncotarget       Date:  2017-01-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.